The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume 37, Issue 20, Pages 1582-1590
Publisher
Oxford University Press (OUP)
Online
2016-02-27
DOI
10.1093/eurheartj/ehw054
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
- (2015) Karel G.M. Moons et al. ANNALS OF INTERNAL MEDICINE
- Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation
- (2014) Lars Wallentin et al. CIRCULATION
- Towards better clinical prediction models: seven steps for development and an ABCD for validation
- (2014) E. W. Steyerberg et al. EUROPEAN HEART JOURNAL
- Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy
- (2014) Ziad Hijazi et al. HEART
- Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- External validation of a Cox prognostic model: principles and methods
- (2013) Patrick Royston et al. BMC Medical Research Methodology
- High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation
- (2013) Ziad Hijazi et al. CIRCULATION
- Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference
- (2013) P. Kirchhof et al. EUROPACE
- Biomarkers in atrial fibrillation: a clinical review
- (2013) Z. Hijazi et al. EUROPEAN HEART JOURNAL
- N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation
- (2013) Ziad Hijazi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- High-Sensitivity Troponin T and Risk Stratification in Patients With Atrial Fibrillation During Treatment With Apixaban or Warfarin
- (2013) Ziad Hijazi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation
- (2012) Ziad Hijazi et al. CIRCULATION
- Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study
- (2012) Leif Friberg et al. EUROPEAN HEART JOURNAL
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease
- (2010) Harvey White et al. AMERICAN HEART JOURNAL
- Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale
- (2010) Renato D. Lopes et al. AMERICAN HEART JOURNAL
- Moving the Tipping Point
- (2010) Mark H. Eckman et al.
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPEAN HEART JOURNAL
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
- (2009) Gregory Y.H. Lip et al. CHEST
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started